Prothena Corporation PLC (NASDAQ:PRTA)
| 28.18 Delayed Data As of May 27 |  +1.58 / +5.94%Today’s Change | 23.82 Today|||52-Week Range 79.75 | -42.96% Year-to-Date |
Latest PRTA News | Press Releases
No recent news for Prothena Corporation PLC.
Today’s Trading
| Previous close | 26.60 |
| Today’s open | 26.26 |
| Day’s range | 26.26 - 28.28 |
| Volume | 12,678 |
| Average volume (3 months) | 432,513 |
| Market cap | $1.3B |
Data as of 3:59pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -295.36% |
| Earnings growth (next 5 years) | -189.35% |
| Revenue growth (last year) | +23,414.30% |
| P/E ratio | 18.7 |
| Price/Sales | 11.94 |
| Price/Book | 2.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SRRASierra Oncology Inc | +0.04 | +0.07% |
| XNCRXencor Inc | +0.31 | +1.39% |
| RCUSArcus Biosciences In... | +0.97 | +5.33% |
| ALLOAllogene Therapeutic... | +0.50 | +6.67% |
Data as of 4:00pm ET, 05/27/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $200.6M |
| Annual profit (last year) | $67.0M |
| Net profit margin | 33.39% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Dun Laoghaire, Dublin |
Forecasts
